Trevi Therapeutics (TRVI) Financial Statements

Compare

589 Followers

Trevi Therapeutics Financial Overview

Trevi Therapeutics's market cap is currently $1.47B. The company's EPS TTM is $-0.06; its P/E ratio is -42.49; Trevi Therapeutics is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -132.00K	$ -147.00K	$ 0.00	$ 0.00	$ -50.00K
Operating Income	$ -49.33M	$ -51.52M	$ -33.92M	$ -29.91M	$ -32.48M
EBITDA	$ -49.33M	$ -47.79M	$ -28.58M	$ -27.98M	$ -32.71M
Net Income	$ -42.76M	$ -47.91M	$ -29.07M	$ -29.15M	$ -33.94M
Balance Sheet
Cash & Short-Term Investments	$ 188.26M	$ 107.62M	$ 82.97M	$ 120.51M	$ 36.83M
Total Assets	$ 193.44M	$ 110.90M	$ 89.40M	$ 123.02M	$ 38.48M
Total Debt	$ 753.00K	$ 1.03M	$ 1.34M	$ 9.18M	$ 14.63M
Net Debt	$ -18.16M	$ -33.06M	$ -31.06M	$ -3.41M	$ -22.20M
Total Liabilities	$ 10.20M	$ 11.26M	$ 6.86M	$ 15.56M	$ 21.40M
Stockholders' Equity	$ 183.24M	$ 99.64M	$ 82.55M	$ 107.46M	$ 17.07M
Cash Flow
Free Cash Flow	$ -42.10M	$ -38.29M	$ -31.85M	$ -28.33M	$ -28.95M
Operating Cash Flow	$ -42.09M	$ -38.26M	$ -31.71M	$ -28.18M	$ -28.95M
Investing Cash Flow	$ -94.11M	$ -21.53M	$ 59.43M	$ -107.37M	$ 0.00
Financing Cash Flow	$ 121.01M	$ 61.48M	$ -7.91M	$ 111.31M	$ 20.77M

Currency in USD

Trevi Therapeutics Earnings and Revenue History

Income Statement >

Trevi Therapeutics Debt to Assets

Balance Sheet >

Trevi Therapeutics Cash Flow

Cash Flow >

Trevi Therapeutics Forecast EPS vs Actual EPS

Earnings >